Pancreatic Cancer Research

ResearcherIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'OrsolaNo recent work listed

Alessandra Arcelli

Matched on ORCID iD 0000-0003-0253-8958; OpenAlex author ID A5051804322. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2018: 1 paper · 2019: 3 papers · 2020: 3 papers · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper

Papers 10

  1. Comparative Effectiveness of Chemotherapy Alone Versus Radiotherapy-Based Regimens in Locally Advanced Pancreatic Cancer: A Real-World Multicenter Analysis (PA… Co-author DOI 10.3390/curroncol30060427↗
  2. Pain Relief after Stereotactic Radiotherapy of Pancreatic Adenocarcinoma: An Updated Systematic Review. First author DOI 10.3390/curroncol29040214↗
  3. Definition of Local Recurrence Site in Resected Pancreatic Adenocarcinoma: A Multicenter Study (DOLORES-1). Co-author DOI 10.3390/cancers13123051↗
  4. Stereotactic body radiotherapy vs conventionally fractionated chemoradiation in locally advanced pancreatic cancer: A multicenter case-control study (PAULA-1). Co-author DOI 10.1002/cam4.3330↗
  5. Higher Biologically Effective Dose Predicts Survival in SBRT of Pancreatic Cancer: A Multicentric Analysis (PAULA-1). Co-author DOI 10.21873/anticanres.13975↗
  6. Basics and Frontiers on Pancreatic Cancer for Radiation Oncology: Target Delineation, SBRT, SIB technique, MRgRT, Particle Therapy, Immunotherapy and Clinical … First author DOI 10.3390/cancers12071729↗
  7. Radiotherapy of pancreatic cancer in older patients: A systematic review. Co-author DOI 10.1016/j.jgo.2018.09.007↗
  8. Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis. Co-author DOI 10.1016/j.tranon.2018.08.017↗
  9. Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival. Co-author DOI 10.1186/s12885-019-5790-2↗
  10. Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief. Co-author DOI 10.2147/jpr.s167994↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Alessio Giuseppe Morganti · 10 shared papers, 2018–2023 · strength 0.95
  2. Milly Buwenge · 10 shared papers, 2018–2023 · strength 0.95
  3. Francesco Cellini · 9 shared papers, 2018–2023 · strength 0.86
  4. Gabriella Macchia · 9 shared papers, 2018–2023 · strength 0.86
  5. Savino Cilla Phys · 7 shared papers, 2019–2023 · strength 0.71
  6. S. Cammelli · 6 shared papers, 2018–2022 · strength 0.57
  7. Gian Carlo Mattiucci · 5 shared papers, 2019–2023 · strength 0.45
  8. Renzo Mazzarotto · 4 shared papers, 2020–2023 · strength 0.40
  9. Nicola Simoni · 4 shared papers, 2020–2023 · strength 0.40
  10. Lidia Strigari · 3 shared papers, 2021–2023 · strength 0.38
  11. Mariacristina Di Marco · 4 shared papers, 2019–2023 · strength 0.37
  12. Michele Fiore · 3 shared papers, 2020–2023 · strength 0.31
  13. Vincenzo Valentini · 3 shared papers, 2019–2020 · strength 0.23
  14. Riccardo Casadei · 3 shared papers, 2019–2020 · strength 0.22
  15. Lorenzo Fuccio · 3 shared papers, 2018–2019 · strength 0.21
  16. Domenico Genovesi · 2 shared papers, 2020–2021 · strength 0.20
  17. Elisa Grassi · 2 shared papers, 2018–2020 · strength 0.17
  18. William F. Regine · 2 shared papers, 2019 · strength 0.14
  19. Felipe Ángel Calvo Manuel · 2 shared papers, 2019 · strength 0.14
  20. Robert Clell Miller · 2 shared papers, 2019 · strength 0.14
  21. Sergio Alfieri · 2 shared papers, 2019 · strength 0.14
  22. Francesco Minni · 2 shared papers, 2019 · strength 0.14
  23. Joseph M. Herman · 2 shared papers, 2019 · strength 0.14
  24. Massimo Falconi · 2 shared papers, 2019 · strength 0.14
  25. Michele Reni · 2 shared papers, 2019 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.